Related Experiment Video
Updated: Sep 16, 2025

In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Interaction Between Cardiogenic Shock and Hypothyroidism in Critical Care Medicine
Martina La Licata Benedetto1, Juan P Ricarte-Bratti2, Julieta Lozita2
1Department of Cardiology, Sanatorio Allende, Córdoba, Argentina.
Abstract:
A 44-year-old male smoker presented with progressive dyspnea over 10 days. Admitted while in cardiogenic shock, the patient had severe dyspnea, hypoxia, and hemodynamic instability. Diagnostics showed diffuse lung opacities, bilateral effusions, severe left ventricular dysfunction (ejection fraction [EF], 10%-15%), and a large pericardial effusion. Initial treatments with inotropes and intra-aortic balloon pump failed, necessitating veno-arterial extracorporeal membrane oxygenation and a pericardial window. Lab results confirmed severe hypothyroidism (thyroid stimulating hormone, 76 μU/mL, free T4 0.1 ng/dL). Treatment with intravenous levothyroxine and steroids stabilized the patient, allowing extracorporeal membrane oxygenation weaning by day 10 and significant improvement in cardiac function over 45 days. Hypothyroidism is a rare but reversible cause of cardiogenic shock, impairing myocardial function via reduced contractility and vascular resistance. Early diagnosis and treatment with hormonal therapy and mechanical support are crucial.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy V: Interprofessional Care
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

